Genetic studies have revealed that mutations in the SH2 domain of DOK7 contribute to a subgroup of congenital myasthenic syndromes (DOK7-CMS), an inherited neuromuscular disorder characterized by fatigable muscle weakness.16 This evidence concerns the gene DOK7 and congenital myasthenic syndrome.